|1.||Itoh, Katsumi: 1 article (02/2002)|
|2.||Ichikawa, Takashi: 1 article (02/2002)|
|3.||Hayashi, Ryogo: 1 article (02/2002)|
|4.||Kitazaki, Tomoyuki: 1 article (02/2002)|
|5.||Okonogi, Kenji: 1 article (02/2002)|
|6.||Iizawa, Yuji: 1 article (02/2002)|
|7.||Kitamoto, Naomi: 1 article (02/2002)|
|1.||Invasive Pulmonary Aspergillosis
02/01/2002 - "Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice."
02/01/2002 - "The in vivo efficacy of TAK-457 was evaluated in two models of invasive pulmonary aspergillosis with CDF(1) mice and CBA/J mice with transient neutropenia induced by cyclophosphamide. "
02/01/2002 - "Against the infection in CDF(1) mice, treatment with 10 mg of TAK-457 and 1 mg of amphotericin B/kg reduced the fungal burden in lungs and rescued all mice. "
02/01/2002 - "In the infection model with CBA/J mice, TAK-457 at a dose of 10 mg/kg significantly prolonged the survival time of mice, showing significant reduction of lung chitin levels and the plasma beta-D-glucan levels. "
|4.||Amphotericin B (Amphotericin)